3104NSC Chap.2 Therapeutic Need, Target Discovery and Validation
Therapeutic Need, Target Discovery and Validation
Define therapeutic need
Therapeutic Need, Target Discovery and Validation places therapeutic need, target discovery and target validation on a target-to-patient evidence chain.
The practical task is to compare genetic, biochemical and disease-model evidence before prioritising a target; each step must connect the therapeutic need and biological target to molecular properties, ADME, exposure, effect and an appropriate formulation or delivery choice.
Place therapeutic need at its correct stage in the development chain.
Define the evidential role of therapeutic need — therapeutic need, target evidence, candidate property, exposure observation, effect measure, delivery constraint or synthesis claim — and separate what is measured from what remains inferred.
State whether target discovery supplies a mechanism, comparison, prediction or evidence synthesis, then trace only the downstream molecular-property, ADME, exposure or effect changes it can support.
In Therapeutic Need, Target Discovery and Validation, that distinction keeps target discovery from being mistaken for a molecular mechanism when it instead names an assessment architecture, seminar or evidence dossier.
Use target validation as a discriminating test or control.
Specify which assay, pharmacokinetic observation, pharmacodynamic response, validation result or evidence-synthesis finding would support target validation, and name an alternative result that would weaken it.
Drug target validation
In 3104NSC, drug target validation belongs with therapeutic need and target discovery because students use it to compare genetic, biochemical and disease-model evidence before prioritising a target.
A defensible use of drug target validation should define the term, connect it to the case evidence and test the conclusion through target validation; repeating the phrase without that chain does not demonstrate understanding.
Trace target discovery
For the application — compare genetic, biochemical and disease-model evidence before prioritising a target — connect target evidence to a candidate, formulation or delivery choice without skipping the exposure-effect relationship.
Finish Therapeutic Need, Target Discovery and Validation by stating which experiment or measurement should be run next and why its result could change the interpretation attached to target validation.
Build an evidence chain for therapeutic need: therapeutic need and target; candidate property or interaction; ADME and exposure; observed effect; formulation or delivery constraint.
Place target discovery and target validation at the step they actually test. A candidate described through therapeutic need is not advanced merely because every stage can be named; the links to target discovery and target validation require compatible evidence.
Run a target discovery counterfactual check.
Change one assumption or molecular property associated with target discovery while holding the relevant target and dose conditions stable, then predict the direction of exposure and effect where that prediction is applicable.
Compare it with the target validation evidence; a mismatch between target discovery and target validation may reveal an incorrect mechanism, missing evidence, off-target activity or a delivery limitation.
Rehearse Therapeutic Need, Target Discovery and Validation from target to patient rather than as a list of terms.
Starting with therapeutic need, state the target or therapeutic need, the property or evidence under study, the relevant ADME consequence, the exposure-effect observation and the formulation or delivery implication.
Mark the first unsupported transition between target discovery and target validation, and repair it before adding another candidate claim.
Test with target validation
A complete response should make the task visible before the detail: identify what must be decided, define the relevant terms, connect the evidence to target discovery, and use target validation to test the result.
The final sentence about target validation should answer the question actually asked rather than merely repeat the topic.
The controlling limit is specific: Association with disease does not by itself demonstrate that modulating the target will be therapeutic.
Keep that target validation limit beside the worked example, because it separates a careful 3104NSC answer from one that sounds confident but claims more than the task or evidence supports.
For revision, retrieve therapeutic need, target discovery and target validation without notes, explain their relationship aloud, then complete a changed version of the application: compare genetic, biochemical and disease-model evidence before prioritising a target.
Record the first failed target discovery reasoning move and repair it before attempting another case.
What this chapter covers
- 01
therapeutic need
- 02
target discovery
- 03
target validation
- 04
Applying therapeutic need
- 05
Limits of target discovery and target validation
Worked example: Therapeutic Need, Target Discovery and Validation
- 1State the exact comparison the task requires in Therapeutic Need, Target Discovery and Validation.
- 1Define therapeutic need and place the observation that belongs to it under that heading.
- 1Define target discovery separately, then name the clue that prevents it being collapsed into therapeutic need.
- 1Apply target validation to the same evidence and give a conclusion that respects this limit: Association with disease does not by itself demonstrate that modulating the target will be therapeutic.
Key terms
- therapeutic need
- A disease-related outcome insufficiently addressed by existing prevention, diagnosis or treatment options. Use this definition when the task is to compare genetic, biochemical and disease-model evidence before prioritising a target.
- target discovery
- The identification of a biological molecule or pathway whose modulation may alter a disease-relevant process. Use this definition when the task is to compare genetic, biochemical and disease-model evidence before prioritising a target.
- target validation
- The accumulation of evidence that changing a proposed target produces the intended biological effect with acceptable relevance and specificity. Use this definition when the task is to compare genetic, biochemical and disease-model evidence before prioritising a target.
Therapeutic Need, Target Discovery and Validation FAQ
What is the main task in Therapeutic Need, Target Discovery and Validation?
Compare genetic, biochemical and disease-model evidence before prioritising a target.
How do therapeutic need and target discovery work together?
Use therapeutic need to establish the object or condition, then use target discovery to explain how it changes the outcome being analysed.
What must a 3104NSC answer qualify here?
Association with disease does not by itself demonstrate that modulating the target will be therapeutic.
How should I revise Therapeutic Need, Target Discovery and Validation?
Retrieve therapeutic need, target discovery and target validation, apply them to a changed case, and correct the first point where the evidence no longer supports the conclusion.
Assessment move
Reconstruct the relationship among therapeutic need, target discovery and target validation; complete the chapter application without notes; then test the result against this limit: Association with disease does not by itself demonstrate that modulating the target will be therapeutic.
Working through Therapeutic Need, Target Discovery and Validation in 3104NSC? Sia is AskSia’s AI Biomedical Science tutor — ask any 3104NSC Therapeutic Need, Target Discovery and Validation question and get a clear, step-by-step explanation grounded in how 3104NSC is taught and assessed. Read this chapter free, then take your hardest questions to Sia.
